Costs associated with treatment of insomnia in Alzheimer’s disease caregivers: a comparison of mindfulness meditation and cognitive behavioral therapy for insomnia

Autor: Tanya G. K. Bentley, Daisy Castillo, Nina Sadeghi, Dominique Piber, Judith Carroll, Richard Olmstead, Michael R. Irwin

Publikováno v: BMC Health Services Research, Vol 22, Iss 1, Pp 1-14 (2022)

Abstract Background Among the over 5 million informal caregivers for patients with Alzheimer’s disease (AD) in the United States (US), over 60% experience insomnia. Research on insomnia treatment efficacy in AD caregivers is limited. An ongoing ran

Externí odkaz: https://doaj.org/article/621e45f92903451888a3bb8e08a9185b

Real-world cardiovascular disease burden in patients with atherosclerotic cardiovascular disease: a comprehensive systematic literature review

Autor: Frank O'Neill, Dasha Cherepanov, Tanya G. K. Bentley, Pin Xiang, Yi Qian, David O. Beenhouwer, Wendy Hsiao, Nicole Yurgin

Publikováno v: Current Medical Research and Opinion. 34:459-473

Objective: Based on randomized controlled trials (RCTs), non-fatal myocardial infarction (MI) rates range between 9 and 15 events per 1000 person-years, ischemic stroke between 4 and 6 per 1000 person-years, CHD death rates between 5 and 7 events per

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26b1cfc983e5ab3de76b330dc9b6d46d
https://doi.org/10.1080/03007995.2017.1401529

The Incidence and Health Care Resource Burden of the Myelodysplastic Syndromes in Patients in Whom First-Line Hypomethylating Agents Fail

Autor: Eunice Chang, Steven M. Fruchtman, Tanya G K Bentley, Michael E. Petrone, Sandra E. Kurtin, Michael S. Broder, Sudipto Mukherjee, Christopher R. Cogle, Scott Megaffin

Publikováno v: The Oncologist. 22:379-385

Background Although hypomethylating agents (HMAs) are effective and approved therapies for patients with myelodysplastic syndromes (MDS), many patients do not benefit from treatment, and nearly all ultimately stop responding to HMAs. The incidence an

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9b74a9182e64dc204a8eb16a13f32f2
https://doi.org/10.1634/theoncologist.2016-0211

Increased Clinical and Economic Burden Associated With Peripheral Intravenous Catheter–Related Complications: Analysis of a US Hospital Discharge Database

Autor: Liza G. Ovington, Marian H. Tarbox, Sheila R. Reddy, Robert Hyde, Sangtaeck Lim, Tanya G K Bentley, Erica Adams, Eunice Chang, Michael S. Broder, Gaurav Gangoli, Walt Danker

Publikováno v: Inquiry: A Journal of Medical Care Organization, Provision and Financing
Inquiry: The Journal of Health Care Organization, Provision, and Financing, Vol 56 (2019)

The burden of complications associated with peripheral intravenous use is underevaluated, in part, due to the broad use, inconsistent coding, and lack of mandatory reporting of these devices. This study aimed to analyze the clinical and economic impa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd9c1f816d23b42be1219110944bb4fd
http://europepmc.org/articles/PMC6747868

Cost–effectiveness of treatments for high-risk myelodysplastic syndromes after failure of first-line hypomethylating agent therapy

Autor: Tanya G K Bentley, Christopher R. Cogle, Jesse D. Ortendahl, Michael E. Petrone, Scott Megaffin, Ayanna M. Anene, Sudipto Mukherjee, Thomas J. McKearn

Publikováno v: Expert Review of Pharmacoeconomics & Outcomes Research. 16:275-284

To evaluate optimal salvage therapy in high-risk myelodysplastic syndromes patients who have failed a first-line hypomethylating agent (HMA) therapy, given that treatment choice is challenging.Using published literature and expert opinion, we develop

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4a2832e2f69373d35689969d0a8be1d
https://doi.org/10.1586/14737167.2016.1096200